USPTO 2015–2025 USPTO PatentsView Foreign Corporation

TestCard Ltd.

USPTO PatentsView assignee record - 13 granted patents across 6 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

RSS updates for this company

The verdict

According to USPTO PatentsView, Testcard ranks #21,888 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 6 technology areas.

#21,888
of 49,997 US assignees by volume
29th percentile
by Innovation Score (28.9/100)
5.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R21888 · Foreign Corporation #21,888 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,888/49,997
  • PHOTO-FINISH Tenaya Therapeutics
  • CPC-NARROW G01N · 6 areas
  • INNOV-THIN 28.9/100
  • CLAIMS-SPARSE 5.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Tenaya Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Testcard’s 28.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Testcard

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Testcard's Innovation Score is 28.9/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Testcard?

Each dot is one of Testcard’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Testcard’s own 5.2 claims/patent is at or below the 21.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Testcard vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 0510152025 Granted patents (volume) Avg claims / patent Tenaya Therapeutics, Inc. - 13, 22Tenaya Therapeuti…Teramount Ltd. - 13, 22.31TeramountTerra Quantum AG - 13, 15.46Terra QuantumTerumo BCT Biotechnologies, LLC - 13, 21.54Terumo BCT Biotec…Teva Branded Pharmaceutical Products R&D, Inc. - 13, 13.92Teva Branded Phar…The Armor All/STP Products Company - 13, 22.15The Armor All/STP…The Board of Trustees of the University of Alabama, for and on behalf of the University of Alabama in Huntsville - 13, 16.15The Board of Trus…The Clearing House Payments Company L.L.C. - 13, 21.23The Clearing Hous…TestCard Ltd. - 13, 5.15Testcard
Testcard vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Testcard's grants concentrate

TestCard Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 23.1% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2022. By volume, Testcard sits between Tenaya Therapeutics, Inc. and The Clearing House Payments Company L.L.C..

Testcard's three-year grant acceleration

TestCard Ltd. shows 6 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at TestCard's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows TestCard holds 13 patents at rank #21,924, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near TestCard

By rank, the assignees closest to #21,924 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in TestCard's primary technology class.

Testcard's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 29th percentile higher than 29% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20202021202220242025 2
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
TestCard Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 2 15.4%
2021 3 23.1%
2022 1 7.7%
2024 5 38.5%
2025partial year 2 15.4%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

TestCard Ltd.'s patent record in context - here's where to go next.

  • TestCard Ltd.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 23.1% of its portfolio - see every assignee active in that class. Explore G01N
  • Ranked #21,888 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare TestCard Ltd. against Tenaya Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 28.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.